Earth Alive Clean Technologies Inc.

Earth Alive Clean Technologies Inc. develops, manufactures, and distributes microbial technology-based products in Canada, the United States, Central and South America, Europe, and Africa. The company operates in two segments, Agriculture and Infrastructure & Maintenance. The Agriculture segment offers Soil Activator for organic agriculture; Alga liquid seaweed and Mineralized Seaweed, which are used for plants growing in salty water; CowPots for organic agriculture; FISH Hydrolysate, a food source for probiotics and mycorrhizae; and Big Blue WAVE Sea Minerals, an ionic sea mineral solution. This segment also provides Dr. Marijane, an organic bio-fertilizer for hemp plants. The Infrastructure & Maintenance segment offers EA1, an organic and biodegradable product to control dust; and RapidAll, an organic and biodegradable industrial cleaner. It serves agricultural and mining sectors. The company is headquartered in Lasalle, Canada.

Earth Alive Clean Technologies Inc. trades as EACTF on OTC. The company is classified in Basic Materials / Agricultural Inputs and reports in USD.

The current profile places the business in Agricultural Inputs. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Earth Alive Clean Technologies Inc. can be compared against peers such as CO2 Gro Inc., Serra Energy Metals Corp., Panther Minerals Inc., Manning Ventures Inc., Medra Corporation, Medaro Mining Corp..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $289,178, beta of 8.89, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

EACTF currently shows total debt of N/A and beta of 8.89. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.earthalivect.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.